A study assessing JMB2002 for COVID-19
Latest Information Update: 08 Apr 2021
At a glance
- Drugs JMB 2002 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors Jemincare
- 08 Apr 2021 New trial record
- 02 Apr 2021 According to a Jemincare media release, the drug has been approved to initiate a study in USA by the US FDA.